Consistent engagement with current medical literature enables clinicians to apply the latest evidence-based treatment and integrate research into clinical practice. This approach enhances patient outcomes by facilitating more effective and individualized care.
Today we’re showcasing some of the latest allergy and immunology-related articles published recently across medical journals. The topics in today’s rundown range from systemic lupus erythematosus to asthma and more.
Modifying the Course of Asthma: Mechanisms and Strategies for Clinical Remission
- Current Opinion in Allergy and Clinical Immunology, December 2025
- Description: Asthma management is ongoing a paradigm shift from symptom control and exacerbation prevention toward the more comprehensive goal of clinical remission. This review is timely because biologic therapies, precision medicine, and improved understanding of immunopathological mechanisms have made remission a realistic therapeutic goal. By integrating clinical, functional, and biological outcomes, remission offers a more comprehensive framework for assessing long-term disease control.
- Summary
- Full Text
Eczema Coxsackium: An Unusual Presentation in Atopic Dermatitis and Hand, Foot, and Mouth Disease
- Pediatric Annals, December 2025
- Description: [The authors] report an atypical case of eczema coxsackium in an 8-month-old with a history of atopic dermatitis who presented with a widespread rash and prolonged fevers without typical oral lesions.
- Summary
- Full Text
Mammalian Meat Allergy and Beyond: Overview of Alpha-Gal Syndrome
- Current Opinion in Allergy and Clinical Immunology, November 2025
- Description: Alpha-gal syndrome (AGS) is a unique allergy to the carbohydrate galactose-alpha-1,3-galactose, which is found in mammalian products, excluding humans and Old World primates. As its prevalence increases, we are learning that AGS has broader geographical range and wider medical impact than initially recognized.
- Summary
- Full Text
Dimerization as a Key Feature of Autoreactive IgA Antibody Responses
- Annals of the Rheumatic Diseases, November 2025
- Description: The presence of immunoglobulin A (IgA) autoantibodies has been described in many autoimmune diseases, and some of its characteristics, such as IgA dimerization, are considered a sign of a mucosal origin. However, limited information is available about the (patho)physiological conditions leading to the development of monomeric vs dimeric (autoreactive) IgA in humans. Therefore, [researchers] investigated IgA dimerization in rheumatic autoimmune diseases with a possible mucosal origin, as well as after vaccination.
- Summary
- Full Text
CARing About Autoimmune Disorders. Use of Chimeric Antigen Receptor Engineered T-Cells in Autoimmune Diseases
- Blood Reviews, November 2025
- Description: This review explores the evolving role of CAR T-cells in reprogramming immune tolerance and achieving durable remission in autoimmune disorders
- Summary
- Full Text
Dysregulated Soluble Immune Mediators and Lupus-Associated Autoantibody Specificities Inform the Development of Immune Indexes that Characterise Classified SLE Transition and SLE Disease Activity
- Lupus Science & Medicine, November 2025
- Description: Systemic lupus erythematosus (SLE) is a complex autoimmune disease. Significant morbidity and early mortality necessitate early intervention. This study harnessed SLE-associated immune dysregulation to create a Lupus Classification Risk Index (LCRII) and Lupus Disease Activity Immune Index (LDAII) that identified individuals at risk for SLE classification and disease activity.
- Summary
- Full Text
Look forward to more journal-focused topics in the coming weeks.
Sign up for alerts and stay informed on the latest published articles and guidelines.
Copyright © 2025 Guideline Central, all rights reserved.